Go Unlimited with Magzter GOLD
Get unlimited access to 10,000+ magazines, newspapers and Premium stories for just
Try GOLD - Free
Nifty 50 EPS may rise at CAGR of 5-6% over next two years: Analysts
Business Standard
|May 14, 2025
The Nifty 50 underlying EPS has grown at an annualised rate of 21.1 per cent in the last 51 months beginning March 2021.
-
As a result, it more than doubled during the period, growing from ₹503 at the end of March 2021 to ₹1,071 now.
The index EPS tracks the combined net profits of 50 listed companies that are part of the index on a trailing 12-month basis.
It is calculated by dividing the index's "end of the day" value with its reported "price-to-earnings" multiple for the day.
The Nifty 50 ended Tuesday's trading session with a trailing price-to-earnings multiple of 22.94 and a closing index value of 24,578.35 according to the data from Bloomberg.
The index EPS trajectory is likely to change a bit by the end of this month because only 33 of the 50 index companies have reported their quarterly results for Q4FY25 till the end of May 12, 2025.
This story is from the May 14, 2025 edition of Business Standard.
Subscribe to Magzter GOLD to access thousands of curated premium stories, and 10,000+ magazines and newspapers.
Already a subscriber? Sign In
MORE STORIES FROM Business Standard
Business Standard
Primary drivers
Mega IPOs could boost interest in Indian markets
2 mins
June 22, 2026
Business Standard
Shifting composition
Dependence on services exports is increasing
2 mins
June 22, 2026
Business Standard
Liquidity view fuels CRR hike possibility
Market participants have started discussing the possibility of a cash reserve ratio (CRR) hike, as expectations grow inflows linked to recent Reserve Bank of India (RBI) measures could add significant liquidity to the banking system.
2 mins
June 22, 2026
Business Standard
India’s $42-bn smartphone festival plans look dispirited
Quadrupling memory chip prices, likely shortages in 2027, and ₹ depreciation to keep prices elevated
3 mins
June 22, 2026
Business Standard
Hyderabad firm builds over ₹400 cr pharma biz, without a factory
HRV Pharma owns drug master files and customer relationships, while outsourcing production to a network of 53 manufacturing partners
3 mins
June 22, 2026
Business Standard
Sebi mulls easing deep disclosures for FPIs
In a bid to stem the ebbing tide of foreign portfolio investment (FPI) flows on Dalal Street, the Securities and Exchange Board of India (Sebi) is reviewing the granular disclosure framework pertaining to ultimate beneficial ownership for FPIs, originally introduced in August 2023, including the mandate that they must invest in at least three Indian stocks.
2 mins
June 22, 2026
Business Standard
Bharat Forge to ride on CV biz, defence deals
The stock advanced 7% over the past month, outperforming the Nifty 50
2 mins
June 22, 2026
Business Standard
West Asia conflict tightens the tap on startup funding
The West Asia conflict is weighing heavily on India’s startup funding options, with investors turning cautious, delaying deployments and becoming increasingly selective amid heightened geopolitical uncertainty.
3 mins
June 22, 2026
Business Standard
India may seek sunset clause in US trade deal
India may press for an automatic review mechanism in its proposed interim trade deal with the United States (US), mirroring a sunset clause introduced by the European Parliament in its trade agreement with Washington, people aware of the negotiations said.
2 mins
June 22, 2026
Business Standard
With healthy and missionary zeal
After the consolidation of the country’s food security by ensuring abundant grain production, the next pertinent step is to focus on nutritional security to manage health-related issues attributable to poor or flawed nourishment.
3 mins
June 22, 2026
Listen
Translate
Change font size